Literature DB >> 218481

Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis.

A Nosal, L A Schleissner, F S Mishkin, J Lieberman.   

Abstract

Angiotensin-converting enzyme assays and gallium-scan results were obtained from 27 patients with biopsy-proven, clinically active sarcoidosis. Twenty-three of these patients had elevated converting enzyme levels, and 22 had positive gallium-scan results. Three of four patients with normal or borderline-elevated levels of angiotensin-converting enzyme also had positive gallium-scan results. Of 156 nonsarcoid patients (pulmonary and other diseases), 27 were found to have elevated serum converting enzyme levels, and 25 of these had negative gallium-scan results. These results indicate that the combination of an assay of angiotensin-converting enzyme and gallium scan increases diagnostic specificity from 83% to 99% without sacrificing sensitivity. We conclude that the concurrent use of angiotensin-converting enzyme assay and gallium scan is of value in the diagnosis of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218481     DOI: 10.7326/0003-4819-90-3-328

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

1.  The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme.

Authors:  S K Zorn; C A Stevens; E N Schachter; J B Gee
Journal:  Lung       Date:  1980       Impact factor: 2.584

2.  Thoracic imaging with gallium-67.

Authors:  H Klech; H Köhn; M Huppmann; W Pohl
Journal:  Eur J Nucl Med       Date:  1987

Review 3.  Calcium and vitamin D metabolism in granulomatous diseases.

Authors:  M Fuss; T Pepersack; C Gillet; R Karmali; J Corvilain
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?

Authors:  R Meliconi; E Lalli; R M Borzì; C Sturani; V Galavotti; G Gunella; R Miniero; A Facchini; G Gasbarrini
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

5.  Endothelin-1 in idiopathic pulmonary fibrosis.

Authors:  M Uguccioni; L Pulsatelli; B Grigolo; A Facchini; L Fasano; C Cinti; M Fabbri; G Gasbarrini; R Meliconi
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

6.  Sarcoidosis: a truly protean disease.

Authors:  V Lopez-Majano
Journal:  Eur J Nucl Med       Date:  1984

7.  67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes.

Authors:  H Köhn; H Klech; A Mostbeck; F Kummer
Journal:  Eur J Nucl Med       Date:  1982

8.  Isolated neurosarcoidosis--a diagnostic enigma: case report and discussion.

Authors:  H S Randeva; R Davison; V Chamoun; P M G Bouloux
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

9.  Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis.

Authors:  M Myslivecek; V Husák; V Kolek; M Budíková; P Koranda
Journal:  Eur J Nucl Med       Date:  1992

10.  Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage.

Authors:  D Beaumont; J Y Herry; M Sapene; P Bourguet; J J Larzul; B de Labarthe
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.